Group 1 - BGM Group Ltd. has completed the acquisition of YX Management Company Ltd., enhancing its capabilities in intelligent mobility technology, with a valuation of US$95.0 million [1][2] - Following the acquisition, YX's shareholders own approximately 32.6% of BGM's equity interests and about 2.2% of the total voting power [1] - The acquisition is a significant step in BGM's AI-driven transformation, aimed at integrating AI into its core businesses, including intelligent insurance and digital services [2][3] Group 2 - The CEO of BGM stated that the integration of YX's expertise will accelerate the application of AI across key sectors, advancing towards an AI Agent-driven model [3] - BGM focuses on technology fields such as AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals [4] - The group utilizes advanced analytics and AI Agent technology to provide comprehensive AI solutions for insurance companies, covering various key scenarios [5] Group 3 - In the biopharmaceutical sector, BGM's division produces oxytetracycline API, crude heparin sodium, and licorice preparations, integrating AI-assisted decision-making for supply chain optimization [6]